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from Pfizer. Pfizer had no role in the design, conduct, interpretation, or publication of this study. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.1971 SAT0417 GRADUAL PROGRESSIVE CHANGE TO EQUAL PREVALENCE Background: Classic ankylosing spondylitis (AS) with radiographic sacroiliitis has long been considered to be more common in men than women. But this difference has gradually decreased with increasing recognition of this condition in women so that the more recent data suggest a range of 2:1 to 1.2:1 ratio in favor of men [1] . 
OF ANKYLOSING SPONDYLITIS AMONG MALES AND FEMALES IN SWITZERLAND: DATA FROM THE SWISS ANKYLOSING SPONDYLITIS SOCIETY (SVMB)
H
Conclusions:
AS is now being recognized as often in females as in males, as reflected in the membership of SVMB over the last 36 years. There can be various reasons for this observation, one of them being the availability of better imaging tools to recognize AS/axial spondyloarthritis (axSpA), especially among women whose disease is clinically and radiologically less pronounced and is therefore often overlooked [2] . For example, the use of MRI (for early detection of spinal inflammation) and the ASAS criteria have resulted in >50% females in a German cohort of patients with nonradiographic axSpA [3] . SVMB has played a major role in achieving greater disease recognition in Switzerland by increasing disease awareness and educating patients and their families, the general public, the governing bodies and the allied health professionals about AS, and by interacting closely with rheumatologists. Other possible factors influencing our data include: women outliving men, forming a little greater percentage of the general population, and possibly more likely to join patient self-help groups and societies, We did not investigate any gender difference in disease severity and clinical presentation. In conclusion, AS/axSpA almost equally afflicts men and women in Switzerland. Background: Several studies describe an association between anxiety, depression and disease activity in Spondyloarthritis (SpA).
